Dantrolene sodium is a type of drug that depresses excitation-contraction coupling in skeletal muscle. It acts by binding the ryanodine receptor 1 and decreasing intracellular calcium concentration. It is used to treat certain medical conditions, caused by nerve disorders, such as spinal cord injury and stroke. The dantrolene sodium used in treatment of muscle stiffness and tightness (spasticity), multiple sclerosis, and cerebral palsy. It is known as a postsynaptic muscle relaxant as it mediates the release of calcium from the sarcoplasmic reticulum, which is essential for muscle contraction.
"What is particularly egregious about SBR's [SBRHA’s] 'offer of proof ' [made during the July 2013 trial] is that it is completely inconsistent with Dr. Kern's April 18, 2013 deposition testimony. This Commission need not look any further than the first patient case, patient E.O., to determine that the offer of proof is grossly inaccurate at best and a fraudulent misrepresentation to this Commission at worst.
Missouri (MO) State Board of Registration for the Healing Arts (SBRHA)
physician professionalism.
Brett Snodgrass, MD
physicians is overseen by state medical boards (SMBs)
“unfathomable and deeply disturbing [sic],”
“wholly unworthy of a state agency [sic],”
Commissioner Dandamudi’s 2013 proposed report
misconduct by the SBRHA.
severity
Dr. Adem’s
Morton Kern, MD,
Commissioner Dandamudi
SBRHA may have committed fraud
Dr. Jonathan Tobis
State Board of Registration (SBR)
The SBRHA tried to frame Dr. Adem several times
Fifth, if a single act of misrepresentation or fraud is a threat to the public, should consideration be given to the need to discipline the members of the SBRHA for their deceptive regulatory conduct
The SBRHA’s disruption of the practice of medicine was profound, and investigation and research into the causes of the unacceptable regulatory conduct are needed